What does Cannonau Corp. do?

Cannonau Corp. (CNNC) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is CNNC's market cap?

Cannonau Corp. (CNNC) has a market capitalization of approximately $72,413, as of August 25, 2026, based on the most recent share price and shares outstanding.

Does CNNC pay a dividend?

No — Cannonau Corp. (CNNC) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

CNNC

Cannonau Corp.

OTC·Drug Manufacturers, Specialty & Generic · Healthcare

$0.00$0.00+0.00%

Market cap$72.41K·Market closed·Aug 25 8:00 PM UTC

Price Chart

$0.00+$0.00 (+0.00%)today

−99.78%CAGR −70.64%

Select date range

FromTo

Mar 12, 2010Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

CNNC does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateJun 7

Last Report DateMay 15

Reported vs Estimate$0.15 vs $2.09

Earnings Surprise−92.8%

FinancialsFinancials Tab

Revenue$0.00

Net Income$338.24K

Net Margin—

Operating Cash Flow−$157.00

Capital Expenditures$0.00

Free Cash Flow−$157.00

Return on Equity—

Return on Invested Capital0.0%

Net Cash$61.00

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for CNNC and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how CNNC's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for CNNC and 80,000+ other tickers.

About Cannonau Corp.

Cannonau Corp. specializes in the development and marketing of products based on cannabidiol. The company, which was established in 2007, previously operated as Pacific Blue Energy Corp. before officially rebranding to Cannonau Corp. in August 2019. Its operations are headquartered in Skaneateles, New York.

CEO: Markwin Maring
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: OTC
Employees: 4
Website: pbec.biz

Peers

Peers Tab

AZFL

Amazonas Florestal, Ltd

Cap

$25.1K

CBDX

Curative Biosciences, Inc.

Cap

$25.8K

FLHLF

Filament Health Corp.

Cap

$26.2K

Latest News

News Tab

No recent news available.

Frequently Asked Questions About CNNC

What does Cannonau Corp. do?: Cannonau Corp. (CNNC) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is CNNC's market cap?: Cannonau Corp. (CNNC) has a market capitalization of approximately $72,413, as of August 25, 2026, based on the most recent share price and shares outstanding.
Does CNNC pay a dividend?: No — Cannonau Corp. (CNNC) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.